Introducing our latest round up of news from across Edinburgh BioQuarter in the March issue of BioQuarter Bulletin.

Read about the transformative City Mobility Plan that will play a significant role in the success of Edinburgh BioQuarter as the destination evolves and grows over the coming decades, with many of the key elements of the Plan at the heart of our proposals for creating Edinburgh’s Health Innovation District.

We update on recent COVID-19 research and company achievements on BioQuarter including a new Cell and Gene Therapy Training Academy as part of RoslinCT’s expansion plans.

Adam Christie, CEO of CALCIVIS, talk about the company’s innovative dentistry technology and why they chose to locate at Edinburgh BioQuarter.

As always research and innovation continue to progress on BioQuarter including breakthroughs in understanding of brain cancer in children,  repurposing of potential drug treatments for MND and a study of human brain tissue from patients with multiple sclerosis offering a new focus in the search for treatments.

We end this issue with an In Brief summary of business and community news.

READ NOW

Keep up to date with all the news, views and future developments at Edinburgh BioQuarter.
Sign Up to BioQuarter Bulletin